The Impact of the COVID-19 Pandemic on Skin Cancers treated with Mohs Micrographic Surgery: A Retrospective Analysis at a Single United States Academic Institution

Main Article Content

Laila Abbas
UT Southwestern Medical Center

Jennifer Wang
UT Southwestern Medical Center

Rajiv Nijhawan
UT Southwestern Medical Center

Divya Srivastava
UT Southwestern Medical Center

Keywords

COVID-19, pandemic, outcomes, Mohs Micrographic surgery

Abstract

Abstract not available.

References

1. Nolan GS, Dunne JA, Kiely AL, et al. The effect of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, prospective cohort study and survey of Plastic Surgeons. BJS (British Journal of Surgery). 2020;107(12):e598-e600.

2. Geskin LJ, Trager MH, Aasi SZ, et al. Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic. J Am Acad Dermatol. 2020;83(1):295-296.

3. Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB. Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic. Br J Dermatol. 2020;183(4):792-794.

4. Andrew TW, Alrawi M, Lovat P. Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic. Clin Exp Dermatol. 2021;46(1):145-146.

5. Capitelli-McMahon H, Hurley A, Pinder R, Matteucci P, Totty J. Characterising non-melanoma skin cancer undergoing surgical management during the COVID-19 pandemic. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2020:S1748-6815(1720)30539-30538.

Article Sidebar

PDF
Published
Jul 9, 2021
DOI https://doi.org/10.25251/skin.5.4.10

Article Details

How to Cite
Abbas, L., Wang, J., Nijhawan, R., & Srivastava, D. (2021). The Impact of the COVID-19 Pandemic on Skin Cancers treated with Mohs Micrographic Surgery: A Retrospective Analysis at a Single United States Academic Institution. SKIN The Journal of Cutaneous Medicine, 5(4), 403–405. https://doi.org/10.25251/skin.5.4.10
Issue
Vol. 5 No. 4 (2021)
Section
Research Letters
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)